BioSpace News Archive

BridgeBio Pharma, Inc., a clinical-stage biopharmaceutical company focused on genetic diseases, announced that on April 5, 2021, the compensation committee of BridgeBio’s board of directors granted 19 new employees restricted stock units for an aggregate of 32,691 shares of the Company’s common stock.

TestDirectly connects medical labs with school districts for comprehensive and easy to implement COVID-19 testing solutions.

FDA Fast Track Designation has been granted to DAV132 for the prevention of Clostridioides difficile infection, a life-threatening condition with persistent unmet medical need, especially in cancer patients

CM Life Sciences III Inc. announced that it priced its initial public offering of 48,000,000 units at $10.00 per unit.

TransMedics Group, Inc. announced that after the review of TransMedics’ clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration has issued a favorable vote in support of approval of the OCS Heart System to the FDA’s Office of Health Technology 2.

Esya Labs, which is developing several ground-breaking novel research assays, today has announced that Novartis is among the first companies to use its technology.

The vast majority of patients make their end-of-life care wishes known to loved ones, and nearly 90% of the time those wishes were carried out according to Kaiser Permanente research published April 6, 2021, in the medical journal JAMA Network Open.

Fastest Labs, a Drug, Alcohol and DNA Testing franchise, has welcomed a new franchise to the system in Sandy, Utah, which opened its doors in November 2020.

Eclipse, a US-based medical device manufacturer, is excited to introduce the DermaFlex line of microcannulas.

Michelson Medical Research Foundation and the Human Vaccines Project are now welcoming applications for the 2021 Michelson Prize: Next Generation Grants.